The 35th CINP World Congress of Neuropsychopharmacology

Presentation information

Print

[CINP2024] Poster Session

CINP2024 » Poster Session

Schizophrenia 1 - Clinical (1)

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

[P129] Safety and efficacy of different initial doses of lurasidone in the schizophrenia treatment: A randomized, open-label, multi-center study

*Qi Liu1, Qi Wu2, Xin Yu3 (1. Peking University Sixth Hospital, 2. Sumitomo Pharma (China) Co., Ltd., 3. Peking University Sixth Hospital )

Keywords:Lurasidone, Safety, Efficacy, Discontinuation rate, Schizophrenia

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password